Open (More or Less) Post on Covid 6
Sep. 14th, 2021 11:38 am![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png){kind=small}
ecosophia
The semi-open posts I've hosted here on the Covid-19 narrative, the inadequately tested experimental drugs for it, and the whole cascading mess surrounding them have continued to field a gargantuan (and increasing) number of comments, so I'm opening another space for discussion. The rules are the same as before: 1. If you plan on parroting the party line of the medical industry and its paid shills, please go away. This is a place for people to talk openly, honestly, and freely about their concerns that the party line in question is dangerously flawed and that actions being pushed by the medical industry et al. are causing injury and death. It is not a place for you to dismiss those concerns. Anyone who wants to hear the official story and the arguments in favor of it can find those on hundreds of thousands of websites.
2. If you plan on insisting that the current situation is the result of a deliberate plot by some villainous group of people or other, please go away. There are tens of thousands of websites currently rehashing various conspiracy theories about the Covid-19 outbreak and the vaccines. This is not one of them. What we're exploring is the likelihood that what's going on is the product of the same arrogance, incompetence, and corruption that the medical industry and its tame politicians have displayed so abundantly in recent decades. That possibility deserves a space of its own for discussion, and that's what we're doing here.
3. If you don't believe in treating people with common courtesy, please go away. I have, and enforce, a strict courtesy policy on my blogs and online forums, and this is no exception. The sort of schoolyard bullying that takes place on so many other internet forums will get you deleted and banned here. No, I don't care if you disagree with that: my journal, my rules.
With that said, the floor is open for discussion.
(no subject)
Date: 2021-09-20 03:41 am (UTC)4:09:46
“The next speaker is Dr. Jessica Rose.”
“My name is Dr. Jessica Rose and I’m a viral immunologist and computational biologist. I’ve taken it upon myself to become a VAERS analyst to organize the data to comprehend the figures to convey information to the public in both published work and video medium.”
“Safety and efficacy are the cornerstones of the development and administration of biologi -- biological products meant for human use. The risk is a measure of the probability of an adverse event occurring and the severity of the resulting harm to health of individuals in a design population. Safety is the judgment of the acceptability of this risk in a specified situation. Efficacy is the probability of benefit to individuals in the design population from a medical technology.”
“Refer to slide one. This is a bar plot that shows the past ten years of VAERS data plotted against the total number of adverse event reports for all vaccines for the years 2011 through 2020 and for covid associated products only for 2021. The left side plot represents all adverse event reports and the right side plot represents all death adverse event reports. There is an over 1000% increase in the total number of adverse events for 2021 and we are not done with 2021. This is highly anomalous on both fronts. These increased reporting rates are not due to increased rates in injections and not due to simulated reporting. This has been shown using a comparative analysis of influenza data.”
“The onus is on the public health officials, the FDA, the CDC and policy makers to answer to these anomalies and acknowledge the clear risk signals emerging from VAERS data and to confront the issue of covid injectable product's use risk that in my opinion outweigh any potential benefit associated with these products, especially for children.”
“Slide two. This is a times series plot that shows the total cumulative number of cardiovascular, immunological, and neurological adverse events for 2021 associated with covid products. When accumulative absolute counts are normalized for the total number of fully injected individuals in the US, we can see that one in six hundred and sixty individuals are succumbing to and reporting immunological adverse events associated with the covid products. The under-reporting factor is not considered here.”
“Slide three. This is a phylogenetic tree showing the emergence of the alpha and delta variants of the covid 19 -- of covid 19 over time. The emergence of both of these variants and their subsequent clustering arose in very close temporal proximity to the rollout of the covid products in Israel. Israeli data from the ministry of health and Our World in Data reveals that 98.1… speech overlaid by a foreign language… Oh my god.”
[pause]
“Oh my god. Sorry about that. Israel is one of the most injected countries and it appears from this data that this represents a clear failure of these products to provide protective immunity against emergent variants and to prevent transmission regardless of how many additional shots administered and this begs the question as to whether these injection rollouts are driving the emergence of the new variants. There is clear and present danger of the emergence of variants of concern if we continue with these alleged booster shots. Thank you.”
“Thank you Dr. Rose.”
4:13:20
“Uhm next speaker is Dr. Retsef Levi”
“Good afternoon everybody. Good afternoon everybody. My name is Restef Levi I hope you can see my personal title slide labeled as slide A on the bottom right. I’m on the faculty of the MIT Sloan School of Management. I have no conflict of interest to disclose today and my presentation represents only my individual opinion and does not reflect in any way of the positions of MIT.”
“Next to slide B. Since Pfizer’s request for the approval of the boosters is partially based on the so-called study conducted in Israel, it is important to understand that the booster vaccination campaign in Israel was anything but a carefully designed study. In a matter of less than six weeks Israel moved from its initial intention to vaccinate the over 60 population to vaccinating anyone above the age of 12 and it is now about to mandate booster vaccinations for anyone to maintain green passport status. This does not allow any reliable learning, definitely not in such a short amount of time and please understand that these adverse events reporting system in Israel is truly dysfunctional particularly around the booster deployment. I know, from personal experience, that the Ministry of Health in Israel does not address appropriately major concerning safety signals. Next to slide C. This leaves us with the question: what drove this massive booster deployment?”
“Next to slide D. Trying to reach vaccine induced herd immunity by reducing transmission rates would be consistent with the stated goal of the agreement that Israel signed with Pfizer. As you can see on slide D on the left hand side. The problem is that by now we already know from mounting evidence that reaching herd immunity based on the current vaccines does not seem like a feasible or realistic goal. Surprisingly, as you can see on the right hand side of slide D Israel continues to have among the highest infection rates per capita in the world.”
“Next to slide E. You all listened to a presentation of the Israeli Ministry of Health that praises the efficacy of the booster. I would like to caution this premature celebration and remind you that similar statements were made just six months ago around February on the two initial doses. Note on slide E on the right hand side that covid 19 deaths in Israel in spite of all of the boosters are on the rise whereas in other countries including many states in the US they seem to be on a downward trend at the moment. The data from Israel also highlights the main risk of serious covid 19 outcomes is focused to large extents among -- among the completely unvaccinated population and almost entirely in the over 61. On the left hand side of slide E you can also see data from table 1 in a research paper by the Ministry of Health in Israel that suggests that the benefit from the boosters compared to the prior two doses in preventing serious illness might be much more limited than desired. There is much more to say about the problems of the current booster efficacy study.”
“Next to slide F. But let me conclude by stressing how important it is to transition from emergency strategies to long term ones. Slide F outlines five important considerations in doing so. They are self explanatory. I hope you will hold off on approving this booster for broad use at least until such a strategy is developed. Thank you for your attention.”
“Thank you Dr. Levi.”